Radiologic Evaluation and Breast Density (READ)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00117663 |
Recruitment Status
: Unknown
Verified September 2009 by Kaiser Permanente.
Recruitment status was: Recruiting
First Posted
: July 8, 2005
Last Update Posted
: September 14, 2009
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Drug: Cessation of Hormone Replacement Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1500 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double |
Primary Purpose: | Diagnostic |
Official Title: | A Population-Based Randomized Trial to Assess the Effects of Short-Term Cessation of Hormone Replacement Therapy (HRT) on Mammography Assessments and Breast Density |
Study Start Date : | November 2004 |
Estimated Study Completion Date : | November 2006 |

- Mammogram recall for additional imaging
- Mammographic breast density
- HRT cessation post study
- Menopausal symptoms
- Adverse events

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 45 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 1 or more prior screening mammograms at Group Health Cooperative within the past 2 years
- Currently taking HRT
- Taking HRT at prior screening mammogram
- Due for a screening mammogram
Exclusion Criteria:
- BI-RADS breast density of 1 (entirely fat)
- Previous cardiovascular events (heart surgery, catheterization, stent bypass, angioplasty, stroke, DVT)
- Previous breast cancer
- History of breast implants
- Breast reduction since last mammogram
- Mastectomy
- History of using Tamoxifen or Raloxifene
- Declined contact or use of data for research

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00117663
Contact: Dawn Fitzgibbons, MPH | 206-287-2380 | fitzgibbons.d@ghc.org |
United States, Washington | |
Group Health Research Institute | Recruiting |
Seattle, Washington, United States, 98101 | |
Contact: Linda Palmer, RN 206-287-2732 palmer.l@ghc.org | |
Principal Investigator: Diana SM Buist, Ph.D. |
Principal Investigator: | Diana SM Buist, Ph.D. | Kaiser Permanente |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00117663 History of Changes |
Other Study ID Numbers: |
DAMD17-03-1-0447 |
First Posted: | July 8, 2005 Key Record Dates |
Last Update Posted: | September 14, 2009 |
Last Verified: | September 2009 |
Keywords provided by Kaiser Permanente:
Randomized controlled trial Mammography health care setting hormone replacement therapy |
breast density mammography performance Breast Carcinoma |
Additional relevant MeSH terms:
Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs |